Crossmark

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R–CHOP chemotherapy

Crossref DOI link: https://doi.org/10.1038/s41598-024-62057-4

Published Online: 2024-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kwak, Kunye https://orcid.org/0009-0005-5908-2607
Park, Yong

Kim, Byung Soo

Kang, Ka-Won https://orcid.org/0000-0003-1462-0502
Funding

Funding for this research was provided by:

Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (HI22C0999, HI22C0999)
License Information

Text and Data Mining valid from 2024-05-16

Version of Record valid from 2024-05-16
More Information

Article History

Received: 2 January 2024

Accepted: 13 May 2024

First Online: 16 May 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below